Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Masimo completes its initial public offering

Executive Summary

After withdrawing an initial public offering in 2001, Masimo (noninvasive cardiovascular monitoring devices) has finally gone public. It had originally hoped to sell 11.9mm common shares, but instead sold 3.3mm (including the overallotment) at $17 each--the midpoint of the anticipated range--netting $48mm. Current shareholders also sold 10.4mm shares.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies